This Q3 2024 update covers listed health and wellbeing performance, M&A and capital-raising activity, and the strategic buyer dynamics shaping the sector.
It is supported by Edison research data to give founders and boards an objective view of value across health, wellness, personal care and pharmaceuticals.
Read the full report
This report is available on request. Share a few details and we will send it to your inbox, then the download will start here.
More in Health, Wellbeing & Pharmaceuticals
Want early access to our next report?
Register your interest and we will share our latest sector insight as it is published.
Access the report
Tell us where to send it and the report will download right away. We will only use your details to share relevant Edison insight.
Thank you.
Your download should begin automatically. If it does not, use the button below.
Download the report ↓